MCM
DNA icon

MV Capital Management’s Ginkgo Bioworks DNA Stock Holding History

MV Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-137
Closed -$1.12K – 1043
2024
Q3 		$1.12K Sell
137
-1
-0.7% -$10 ﹤0.01% 738
2024
Q2 		$1.84K Sell
138
-1
-0.7% -$30 ﹤0.01% 661
2024
Q1 		$6.43K Buy
139
+1
+0.7% +$52 ﹤0.01% 576
2023
Q4 		$9.29K Hold
138
– – ﹤0.01% 532
2023
Q3 		$9.96K Hold
138
– – ﹤0.01% 500
2023
Q2 		$10.2K Hold
138
– – ﹤0.01% 508
2023
Q1 		$7.32K Hold
138
– – ﹤0.01% 549
2022
Q4 		$9.29K Hold
138
– – ﹤0.01% 469
2022
Q3 		$17K Buy
+138
New +$16.4K ﹤0.01% 355

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return